Gut peptides in the control of food intake (Q37442631)

20 August 2017

1 reference

title

Gut peptides in the control of food intake (English)

1 reference

20 August 2017

T H Moran

1

1 reference

PubMed ID

19363513

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

International Journal of Obesity

20 August 2017

1 reference

20 August 2017

33 Suppl 1

1 reference

20 August 2017

S7-10

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2009.9

20 August 2017

0 references

cites work

2-Deoxy-D-glucose and mercaptoacetate induce different patterns of macronutrient ingestion.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Hyperphagic effects of brainstem ghrelin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Lateral ventricular ghrelin and fourth ventricular ghrelin induce similar increases in food intake and patterns of hypothalamic gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Absence of ghrelin protects against early-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Amylin decreases meal size in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

Ghrelin and leptin pulse discharge in fed and fasted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Integration of vagal afferent responses to duodenal loads and exogenous CCK in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Volume regulation in NIH/3T3 cells not expressing P-glycoprotein. II. Chloride and amino acid fluxes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Prolonged incubation of skeletal muscle in vitro: prevention of increases in glucose transport

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Glucagonlike peptide 1: a newly discovered gastrointestinal hormone

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.9

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.9

1 reference

PubMed ID

19363513

Dimensions Publication ID

20 August 2017

0 references

1 reference

PubMed ID

19363513